IntroductionTo investigate the effects of hepatic arterial infusion chemotherapy (HAIC) with or without systemic chemotherapy compared to systemic chemotherapy alone in patients with locally advanced hepatocellular carcinoma (HCC).MethodsFollowing a registered protocol (PROSPERO 2023 CRD42023386780 Available from: https://www.crd.york.ac.uk/prospero/display_record.php?ID=CRD42023386780), a comprehensive search was performed using reputable databases and registries up to December 26, 2022, with no language, publication date, or status restrictions. Only randomized controlled trials (RCTs) investigating the effects of HAIC with or without systemic chemotherapy versus systemic therapy alone were included. The primary outcomes were overall surv...
Copyright © 2014 Ming-Chun Ma et al.This is an open access article distributed under the Creative Co...
Purpose: This multicenter, randomized, open-labeled, clinical trial evaluated the efficacy and safe...
Aim: Sorafenib is the standard treatment for advanced hepatocellular carcinoma (HCC). However, altho...
IntroductionTo investigate the effects of hepatic arterial infusion chemotherapy (HAIC) with or with...
PURPOSE: Hepatic arterial infusion chemotherapy (HAIC) has been reported to be effective in patients...
Background: We compared the clinical efficacies of hepatic arterial infusion chemotherapy (HAIC) vs....
BackgroundIn recent years, hepatic arterial infusion chemotherapy (HAIC) has gained popularity in th...
BackgroundIn recent years, there has been rapid development in systemic therapeutic agents for advan...
Hepatic artery infusion chemotherapy (HAIC) is a well-established and common treatment for advanced ...
PURPOSE: Hepatic arterial infusion chemotherapy (HAIC) has often been used as a therapeutic option f...
Background & Aims: For patients with advanced hepatocellular carcinoma (HCC) who have failed first-l...
Treatment of advanced hepatocellular carcinoma (HCC) remains a significant problem for clinicians. S...
BACKGROUND: Although locoregional treatments such as hepatic arterial infusion (HAI) claim the advan...
Background & Aims: Direct comparisons across first-line regimens for advanced hepatocellular carcino...
Abstract Background In patients with advanced hepatocellular carcinoma (HCC), evidence is unclear as...
Copyright © 2014 Ming-Chun Ma et al.This is an open access article distributed under the Creative Co...
Purpose: This multicenter, randomized, open-labeled, clinical trial evaluated the efficacy and safe...
Aim: Sorafenib is the standard treatment for advanced hepatocellular carcinoma (HCC). However, altho...
IntroductionTo investigate the effects of hepatic arterial infusion chemotherapy (HAIC) with or with...
PURPOSE: Hepatic arterial infusion chemotherapy (HAIC) has been reported to be effective in patients...
Background: We compared the clinical efficacies of hepatic arterial infusion chemotherapy (HAIC) vs....
BackgroundIn recent years, hepatic arterial infusion chemotherapy (HAIC) has gained popularity in th...
BackgroundIn recent years, there has been rapid development in systemic therapeutic agents for advan...
Hepatic artery infusion chemotherapy (HAIC) is a well-established and common treatment for advanced ...
PURPOSE: Hepatic arterial infusion chemotherapy (HAIC) has often been used as a therapeutic option f...
Background & Aims: For patients with advanced hepatocellular carcinoma (HCC) who have failed first-l...
Treatment of advanced hepatocellular carcinoma (HCC) remains a significant problem for clinicians. S...
BACKGROUND: Although locoregional treatments such as hepatic arterial infusion (HAI) claim the advan...
Background & Aims: Direct comparisons across first-line regimens for advanced hepatocellular carcino...
Abstract Background In patients with advanced hepatocellular carcinoma (HCC), evidence is unclear as...
Copyright © 2014 Ming-Chun Ma et al.This is an open access article distributed under the Creative Co...
Purpose: This multicenter, randomized, open-labeled, clinical trial evaluated the efficacy and safe...
Aim: Sorafenib is the standard treatment for advanced hepatocellular carcinoma (HCC). However, altho...